A Sensor Array Composed of Organelle-Targeting Fluorescent Probes and Polydopamine Particles for Deep Learning-Assisted Identification and Ablation of Drug-Resistant Lung Tumors.

Journal: Analytical chemistry
Published Date:

Abstract

Lung cancer, a leading cause of global cancer-related mortality, predominantly features nonsmall cell lung cancer (NSCLC), constituting 80% of all lung malignancies. Despite chemotherapy being the primary NSCLC treatment, the emergence of drug resistance poses a significant challenge. Identifying drug-resistant cells and characterizing the resistance type is crucial for guiding clinical interventions in NSCLC. The homogeneity of drug-sensitive/resistant cancer cells presents a challenge in their identification as well as in distinguishing tumor slices. Organelles, pivotal for cellular function, exhibit notable variations in the microenvironment among diverse cell types. In this work, three organelle-targeting nanoparticles, composed of fluorescent probes and polydopamine particles, collectively formed PPTA-SA (an organelle-targeting sensor array) for imaging NSCLC cells and tumor slices. With a deep learning network, PPTA-SA could be used for identification of drug-resistant lung cells and tumors. The achieved identification accuracy for drug-resistant NSCLC cells and NSCLC tumor slices was more than 99%. Moreover, the multiorganelle targeting photothermal therapy demonstrated superior tumor ablation effects compared to conventional single-organelle targeting photothermal therapy. The combination of fluorescent probes and polydopamine not only served as a valuable tool for drug-sensitive/resistant NSCLC identification but also facilitated photothermal therapy with enhanced effects.

Authors

  • Guoyang Zhang
    Graduate School of Education, Shanghai Jiao Tong University, Shanghai, China.
  • Guanghui Zhu
    Oncology Department, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China.
  • Jiguang Li
    State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing 100029, China.
  • Qian Wu
    China Electric Power Research Institute, Beijing, China.
  • Mingguang Zhu
    State Key Laboratory of Chemical Resource Engineering, College of Chemistry, Beijing University of Chemical Technology, Beijing 100029, China.
  • Kunyi Wang
    Department of Thyroid & Breast Surgery, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
  • Zixuan Zhang
    Department of Electrical & Computer Engineering, National University of Singapore, 4 Engineering Drive 3, Singapore 117576, Singapore.
  • Changsheng Zhao
    Department of Orthopedics, Peking University International Hospital, Beijing 102206, China.
  • Xuefei Wang
    Department of Breast Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zhuo Wang
    Sichuan Center for Disease Control and Prevention, Chengdu 610500, China.

Keywords

No keywords available for this article.